BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 01, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Kamada, Baxter sales and marketing update

Baxter launched once-weekly Glassia in the U.S. to treat alpha-1 antitrypsin (AAT)...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >